Fluorescence lifetime imaging (FLIM) depends on the fluorescence decay differences between tissues to generate image contrast. In the present study FLIM has been applied to fixed (but unstained) breast cancer tissues to demonstrate the feasibility of this approach for histopathological assessment. As the FLIM method relies on natural autofluorescence, it may be possible to circumvent tissue processing altogether and so FLIM has the potential to be a powerful new method of in vivo tissue imaging via an endoscopic or per-operative approach in a variety of organs, as well as a research tool for in vivo animal models of disease. Unstained, alcohol-fixed tissue samples from 13 patients were stimulated by laser pulses at 415 nm. The temporal deca...
This study evaluates the potential for fluorescence lifetime imaging (FLIm) to enhance intraoperativ...
The combination of fluorescence spectroscopy and imaging provides a powerful approachto study the mo...
Re-excision rates for breast cancer lumpectomy procedures are currently nearly 25% due to surgeons r...
Fluorescence lifetime imaging (FLIM) depends on the fluorescence decay differences between tissues t...
Just as medical research has advanced, diseases have also adapted to many treatments and continue to...
Fluorescence lifetime imaging microscopy (FLIM) is a technique that has shown the ability to differe...
Tissue characterization by endoscopic fluorescence imaging of endogenous or exogenous fluorochromes ...
Fluorescence lifetime is not only associated with the molecular structure of fluorophores, but also ...
Abstract The classical examination of histology slides from a mouse model of breast cancer has been ...
AbstractFast and non-invasive, diagnostic techniques based on fluorescence spectroscopy have the pot...
Abstract A biopsy is often performed for the diagnosis of cancer during a surgical operation. In add...
Abstract Background Assessment of the status of tumor biomarkers in individual patients would facili...
In this article, a fluorescence lifetime imaging system for small animals is presented. Data were co...
Fluorescence lifetime imaging microscopy (FLIM) enables detection of complex molecular assemblies wi...
We describe a new fluorescence imaging device for clinical cancer photodetection in hollow organs in...
This study evaluates the potential for fluorescence lifetime imaging (FLIm) to enhance intraoperativ...
The combination of fluorescence spectroscopy and imaging provides a powerful approachto study the mo...
Re-excision rates for breast cancer lumpectomy procedures are currently nearly 25% due to surgeons r...
Fluorescence lifetime imaging (FLIM) depends on the fluorescence decay differences between tissues t...
Just as medical research has advanced, diseases have also adapted to many treatments and continue to...
Fluorescence lifetime imaging microscopy (FLIM) is a technique that has shown the ability to differe...
Tissue characterization by endoscopic fluorescence imaging of endogenous or exogenous fluorochromes ...
Fluorescence lifetime is not only associated with the molecular structure of fluorophores, but also ...
Abstract The classical examination of histology slides from a mouse model of breast cancer has been ...
AbstractFast and non-invasive, diagnostic techniques based on fluorescence spectroscopy have the pot...
Abstract A biopsy is often performed for the diagnosis of cancer during a surgical operation. In add...
Abstract Background Assessment of the status of tumor biomarkers in individual patients would facili...
In this article, a fluorescence lifetime imaging system for small animals is presented. Data were co...
Fluorescence lifetime imaging microscopy (FLIM) enables detection of complex molecular assemblies wi...
We describe a new fluorescence imaging device for clinical cancer photodetection in hollow organs in...
This study evaluates the potential for fluorescence lifetime imaging (FLIm) to enhance intraoperativ...
The combination of fluorescence spectroscopy and imaging provides a powerful approachto study the mo...
Re-excision rates for breast cancer lumpectomy procedures are currently nearly 25% due to surgeons r...